ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

Avastin Improves PFS Compared To Chemo Alone

January 29, 2010

Younger Patients, More Advanced Stages, More Likely To Die From Breast Cancer

September 24, 2004

PI Defends NCI’s National Lung Screening Trial As “Rigorous” Randomized Trial.

November 3, 2006

DCPC Board Approves Nine Concepts, New Small Cancer Control Grants, Rerelease Of FDA For Nutrition Core Grants

January 20, 1984

Centers Structures, Governance, Funding, Review considered By NCI, NCAB, Center Directors

September 30, 1977

Lineberger Endows Chair To Honor Denman Hammond.

April 13, 2001